￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Safety and effectiveness of crizotinib (Xalkori) in the treatment of advanced or metastatic ROS1-rearranged lung cancer

2025-10-19 11:44:20

Check Details
Efficacy data of Lorlatinib in the treatment of NSCLC patients carrying ALK/ROS1 rearrangements

2025-10-19 11:44:20

Check Details
Efficacy and safety of Lorlatinib

2025-10-19 11:44:20

Check Details
Comparison of clinical efficacy data between alectinib and crizotinib in the treatment of lung cancer?

2025-10-19 11:44:20

Check Details
How much does a box of the new anti-cancer drug lorlatinib cost? How much do you eat every day?

2025-10-19 11:44:20

Check Details
Dosage Selection for Patients Taking Capmatinib_Canghule

2025-10-19 11:44:20

Check Details
Safety and effectiveness of dacomitinib (Dozerun) in EGFR-positive advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Is aletinib, the killer weapon against lung cancer, effective?

2025-10-19 11:44:20

Check Details
Safety Trial Status of Crizotinib/Xalkori in Patients with Lung Cancer

2025-10-19 11:44:20

Check Details
Crizotinib in the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Efficacy and safety data of crizotinib (Xalkori) in non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Safety and tolerability of crizotinib in the treatment of positive non-small cell lung cancer_ Kanghule

2025-10-19 11:44:20

Check Details
Category
相关知识